Ivan Kairatov, a notable expert in biopharma with a rich background in tech and innovation within the industry, lends his insights on a recent groundbreaking study in human cell cycle regulation. The study, led by the team at EPFL, unveils how newly evolved genes are integral to the complex process
The question of whether chromosomal changes can be a catalyst for major evolutionary shifts is becoming increasingly pertinent in contemporary evolutionary biology discourse. Major evolutionary shifts, often referred to as macromutations, describe significant transformations in an organism's
In today's world, where the quest for longevity is becoming ever more pressing, a novel question arises: Can enhanced model ranking revolutionize therapies for aging-related diseases? Aging impacts daily life in ways that often go unnoticed, from diminished hearing to slow recovery from illness.
The biopharmaceutical industry finds itself at a crossroads as the ever-increasing global demand for pharmaceuticals necessitates a reevaluation of traditional manufacturing approaches. With escalating costs and inefficiencies hindering timely drug production, the sector is turning towards a
The promise of regenerative medicine lies in its potential to repair or replace damaged tissues, restoring function to affected areas of the body. Recent groundbreaking research has illuminated a new frontier in this field by examining the once-overlooked stem cells residing in the nasal cavity's
The field of tissue engineering faces the persistent challenge of replicating the complex and diverse environments in which cells naturally exist. Traditional techniques often use gels to suspend cells between posts, easing tissue growth but complicating efforts to study how multiple tissue types
